242 related articles for article (PubMed ID: 15075324)
1. Mirk/dyrk1B kinase destabilizes cyclin D1 by phosphorylation at threonine 288.
Zou Y; Ewton DZ; Deng X; Mercer SE; Friedman E
J Biol Chem; 2004 Jun; 279(26):27790-8. PubMed ID: 15075324
[TBL] [Abstract][Full Text] [Related]
2. The cyclin-dependent kinase inhibitor p27Kip1 is stabilized in G(0) by Mirk/dyrk1B kinase.
Deng X; Mercer SE; Shah S; Ewton DZ; Friedman E
J Biol Chem; 2004 May; 279(21):22498-504. PubMed ID: 15010468
[TBL] [Abstract][Full Text] [Related]
3. Rapid turnover of cell-cycle regulators found in Mirk/dyrk1B transfectants.
Ewton DZ; Lee K; Deng X; Lim S; Friedman E
Int J Cancer; 2003 Jan; 103(1):21-8. PubMed ID: 12455049
[TBL] [Abstract][Full Text] [Related]
4. Mirk/Dyrk1B mediates survival during the differentiation of C2C12 myoblasts.
Mercer SE; Ewton DZ; Deng X; Lim S; Mazur TR; Friedman E
J Biol Chem; 2005 Jul; 280(27):25788-801. PubMed ID: 15851482
[TBL] [Abstract][Full Text] [Related]
5. Mirk/dyrk1B decreases the nuclear accumulation of class II histone deacetylases during skeletal muscle differentiation.
Deng X; Ewton DZ; Mercer SE; Friedman E
J Biol Chem; 2005 Feb; 280(6):4894-905. PubMed ID: 15546868
[TBL] [Abstract][Full Text] [Related]
6. Involvement of GSK-3beta and DYRK1B in differentiation-inducing factor-3-induced phosphorylation of cyclin D1 in HeLa cells.
Takahashi-Yanaga F; Mori J; Matsuzaki E; Watanabe Y; Hirata M; Miwa Y; Morimoto S; Sasaguri T
J Biol Chem; 2006 Dec; 281(50):38489-97. PubMed ID: 17046823
[TBL] [Abstract][Full Text] [Related]
7. A novel DYRK1B inhibitor AZ191 demonstrates that DYRK1B acts independently of GSK3β to phosphorylate cyclin D1 at Thr(286), not Thr(288).
Ashford AL; Oxley D; Kettle J; Hudson K; Guichard S; Cook SJ; Lochhead PA
Biochem J; 2014 Jan; 457(1):43-56. PubMed ID: 24134204
[TBL] [Abstract][Full Text] [Related]
8. Serine/threonine kinase Mirk/Dyrk1B is an inhibitor of epithelial cell migration and is negatively regulated by the Met adaptor Ran-binding protein M.
Zou Y; Lim S; Lee K; Deng X; Friedman E
J Biol Chem; 2003 Dec; 278(49):49573-81. PubMed ID: 14500717
[TBL] [Abstract][Full Text] [Related]
9. The transcriptional activator Mirk/Dyrk1B is sequestered by p38alpha/beta MAP kinase.
Lim S; Zou Y; Friedman E
J Biol Chem; 2002 Dec; 277(51):49438-45. PubMed ID: 12384504
[TBL] [Abstract][Full Text] [Related]
10. Mirk regulates the exit of colon cancer cells from quiescence.
Jin K; Ewton DZ; Park S; Hu J; Friedman E
J Biol Chem; 2009 Aug; 284(34):22916-25. PubMed ID: 19542220
[TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor I triggers nuclear accumulation of cyclin D1 in MCF-7S breast cancer cells.
Hamelers IH; van Schaik RF; Sipkema J; Sussenbach JS; Steenbergh PH
J Biol Chem; 2002 Dec; 277(49):47645-52. PubMed ID: 12364325
[TBL] [Abstract][Full Text] [Related]
12. The involvement of cyclin D1 degradation through GSK3β-mediated threonine-286 phosphorylation-dependent nuclear export in anti-cancer activity of mulberry root bark extracts.
Eo HJ; Park GH; Jeong JB
Phytomedicine; 2016 Feb; 23(2):105-13. PubMed ID: 26926171
[TBL] [Abstract][Full Text] [Related]
13. Cold-inducible RNA-binding protein (Cirp) interacts with Dyrk1b/Mirk and promotes proliferation of immature male germ cells in mice.
Masuda T; Itoh K; Higashitsuji H; Higashitsuji H; Nakazawa N; Sakurai T; Liu Y; Tokuchi H; Fujita T; Zhao Y; Nishiyama H; Tanaka T; Fukumoto M; Ikawa M; Okabe M; Fujita J
Proc Natl Acad Sci U S A; 2012 Jul; 109(27):10885-90. PubMed ID: 22711815
[TBL] [Abstract][Full Text] [Related]
14. Ubiquitination of free cyclin D1 is independent of phosphorylation on threonine 286.
Germain D; Russell A; Thompson A; Hendley J
J Biol Chem; 2000 Apr; 275(16):12074-9. PubMed ID: 10766840
[TBL] [Abstract][Full Text] [Related]
15. Differentiation-inducing factor-1 induces cyclin D1 degradation through the phosphorylation of Thr286 in squamous cell carcinoma.
Mori J; Takahashi-Yanaga F; Miwa Y; Watanabe Y; Hirata M; Morimoto S; Shirasuna K; Sasaguri T
Exp Cell Res; 2005 Nov; 310(2):426-33. PubMed ID: 16153639
[TBL] [Abstract][Full Text] [Related]
16. Role of glycogen synthase kinase 3beta in rapamycin-mediated cell cycle regulation and chemosensitivity.
Dong J; Peng J; Zhang H; Mondesire WH; Jian W; Mills GB; Hung MC; Meric-Bernstam F
Cancer Res; 2005 Mar; 65(5):1961-72. PubMed ID: 15753396
[TBL] [Abstract][Full Text] [Related]
17. ErbB2/neu kinase modulates cellular p27(Kip1) and cyclin D1 through multiple signaling pathways.
Lenferink AE; Busse D; Flanagan WM; Yakes FM; Arteaga CL
Cancer Res; 2001 Sep; 61(17):6583-91. PubMed ID: 11522658
[TBL] [Abstract][Full Text] [Related]
18. A potential mechanism for fumonisin B(1)-mediated hepatocarcinogenesis: cyclin D1 stabilization associated with activation of Akt and inhibition of GSK-3beta activity.
Ramljak D; Calvert RJ; Wiesenfeld PW; Diwan BA; Catipovic B; Marasas WF; Victor TC; Anderson LM; Gelderblom WC
Carcinogenesis; 2000 Aug; 21(8):1537-46. PubMed ID: 10910956
[TBL] [Abstract][Full Text] [Related]
19. Mirk/dyrk1B is a Rho-induced kinase active in skeletal muscle differentiation.
Deng X; Ewton DZ; Pawlikowski B; Maimone M; Friedman E
J Biol Chem; 2003 Oct; 278(42):41347-54. PubMed ID: 12902328
[TBL] [Abstract][Full Text] [Related]
20. Effects of cyclin D1 overexpression on G1 progression-related events.
Imoto M; Doki Y; Jiang W; Han EK; Weinstein IB
Exp Cell Res; 1997 Oct; 236(1):173-80. PubMed ID: 9344597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
